Samuel Levy is a distinguished professional in the healthcare sector, currently serving as a Board Member for Natural Cycles°, OrganOx, Veranex, Matrix Requirements, and Reapplix. As a Founding Partner at Lauxera Capital Partners, Samuel focuses on investing in scientifically de-risked healthcare companies. Samuel is also the Founder of Allurion Technologies, known for creating the Allurion Balloon, a groundbreaking approach in the weight loss industry. Previous board membership includes Theraclion and Vensica Medical. Samuel holds an MD from Harvard Medical School and a BS in Molecular Biophysics and Biochemistry from Yale University.